Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Anti-brain spectrin immunoreactivity in Alzheimer's disease: degradation of spectrin in an animal model of cholinergic degeneration.

Fernández-Shaw C, Marina A, Cazorla P, Valdivieso F, Vázquez J.

J Neuroimmunol. 1997 Jul;77(1):91-8.

PMID:
9209273
2.

Abnormal brain spectrin immunoreactivity in sprouting neurons in Alzheimer disease.

Masliah E, Hansen L, Mallory M, Albright T, Terry RD.

Neurosci Lett. 1991 Aug 5;129(1):1-5.

PMID:
1922957
3.

Antibodies in serum of patients with Alzheimer's disease cause immunolysis of cholinergic nerve terminals from the rat cerebral cortex.

Bradford HF, Foley P, Docherty M, Fillit H, Luine VN, McEwen B, Bucht G, Winbald B, Hardy J.

Can J Neurol Sci. 1989 Nov;16(4 Suppl):528-34.

PMID:
2804815
4.

Antimicroglia antibodies in sera of Alzheimer's disease patients.

Lemke MR, Glatzel M, Henneberg AE.

Biol Psychiatry. 1999 Feb 15;45(4):508-11.

PMID:
10071725
5.

Antibodies to cholinergic neurons in Alzheimer's disease.

Chapman J, Bachar O, Korczyn AD, Wertman E, Michaelson DM.

J Neurochem. 1988 Aug;51(2):479-85.

PMID:
3292704
6.

Deafferentation of the septo-hippocampal pathway in rats as a model of the metabolic events in Alzheimer's disease.

Krügel U, Bigl V, Eschrich K, Bigl M.

Int J Dev Neurosci. 2001 Jun;19(3):263-77.

PMID:
11337195
7.

Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss?

Masliah E, Iimoto DS, Saitoh T, Hansen LA, Terry RD.

Brain Res. 1990 Oct 29;531(1-2):36-44.

PMID:
2289136
8.

Brain-derived neurotrophic factor and neurotrophin-3 levels in Alzheimer's disease brains.

Durany N, Michel T, Kurt J, Cruz-Sánchez FF, Cervás-Navarro J, Riederer P.

Int J Dev Neurosci. 2000 Dec;18(8):807-13.

PMID:
11156744
9.
10.

Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States.

Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB.

Invest Ophthalmol Vis Sci. 2006 Mar;47(3):968-76.

PMID:
16505031
11.

Antibodies to human brain spectrin in Alzheimer's disease.

Vázquez J, Fernández-Shaw C, Marina A, Haas C, Cacabelos R, Valdivieso F.

J Neuroimmunol. 1996 Aug;68(1-2):39-44.

PMID:
8784258
12.

Nucleus basalis Meynert lesions and the expression of nicotinic acetylcholine receptor proteins in the rat frontal cerebral cortex.

Burghaus L, Schütz U, Simonnet K, Krempel U, Lindstrom J, Schröder H.

Neurosci Lett. 2001 Mar 30;301(2):111-4.

PMID:
11248435
13.

Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit.

Gil-Bea FJ, García-Alloza M, Domínguez J, Marcos B, Ramírez MJ.

Neurosci Lett. 2005 Feb 25;375(1):37-41. Epub 2004 Dec 10.

14.

Animal model and in vitro studies of anti neurofilament antibodies mediated neurodegeneration in Alzheimer's disease.

Oron L, Dubovik V, Novitsky L, Eilam D, Michaelson DM.

J Neural Transm Suppl. 1997;49:77-84. Review.

PMID:
9266416
15.

Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures.

Dahlström A, Wigander A, Lundmark K, Gottfries CG, Carvey PM, McRae A.

J Neural Transm Suppl. 1990;29:195-206.

PMID:
2358801
16.

Development and characterization of antibodies specific to caspase-3-produced alpha II-spectrin 120 kDa breakdown product: marker for neuronal apoptosis.

Nath R, Huggins M, Glantz SB, Morrow JS, McGinnis K, Nadimpalli R, Wanga KK.

Neurochem Int. 2000 Oct;37(4):351-61.

PMID:
10825575
17.

Spectrin, fodrin, and TW260/240: a family of related proteins lining the plasma membrane.

Glenney JR Jr, Glenney P.

Cell Motil. 1983;3(5-6):671-82.

PMID:
6661770
18.
19.

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.

Lidström AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P, Blennow K.

Exp Neurol. 1998 Dec;154(2):511-21.

PMID:
9878186
20.

Mouse models of Alzheimer's disease: insight into treatment.

German DC, Eisch AJ.

Rev Neurosci. 2004;15(5):353-69. Review.

PMID:
15575491

Supplemental Content

Support Center